Injection, oritavancin (orbactiv), 10 mg
Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.
ORBACTIV is an Antibiotic drug manufactured by Melinta Therapeutics and administered via the Intravenous route of administration. The J Code: J2407 is aligned to the drug ORBACTIV.
ORBACTIV is an anti-bacterial drug commonly used to treat acute bacterial and skin structure infections in adult patients. It is a lipoglycopeptide designed to kill Gram positive bacteria through three mechanisms of action: stopping the polymerization step of cell wall synthesis, stopping crosslinking necessary for cell wall synthesis, and disrupting the bacterial cell wall membrane causing eventual bacterial death. ORBACTIV (J2407) is used most commonly in adults and is contraindicated in patients with hepatic or renal insufficiency. Usage of a drug that is metabolized by the CYP450 enzyme is not advised while taking ORBACTIV. Patient assistance can be found through Orbactiv.
January 1, 2016
October 1, 2021